A
decade of exploring the cancer epigenome — biological and translational
implications
Stephen B. Baylin & Peter A. Jones
p726 | doi:10.1038/nrc3130
Epigenetic alterations are leading candidates for the development of specific markers for cancer detection, diagnosis and prognosis, as well as new targets for cancer therapy. Which of the discoveries in the past 10 years are ready for advancement?
Stephen B. Baylin & Peter A. Jones
p726 | doi:10.1038/nrc3130
Epigenetic alterations are leading candidates for the development of specific markers for cancer detection, diagnosis and prognosis, as well as new targets for cancer therapy. Which of the discoveries in the past 10 years are ready for advancement?
a must read at http://www.nature.com/nrc/journal/v11/n10/pdf/nrc3130.pdf
No comments:
Post a Comment